Zhu Jie, Yu Fei
Department of Pediatric Endocrine and Genetic Metabolic Disease, Maternal and Children's Hospital of Hubei Province, Wuhan 430070, China.
Zhongguo Dang Dai Er Ke Za Zhi. 2017 Jan;19(1):68-72. doi: 10.7499/j.issn.1008-8830.2017.01.011.
Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare autosomal recessive hereditary disease and is a congenital metabolic disorder of neurotransmitter biosynthesis. It is mainly manifested as hypotonia, oculogyric crisis, autonomic dysfunction, and developmental delay. This article reports a boy manifested as delayed motor development, hypotonia, and oculogyric crisis. Gene screening for metabolic disorders revealed new compound heterozygous mutations, c.1063dupA (p.I355fs) and c.250A>C (p.S84R), in the exon of DDC gene. The boy had a significant increase in 3-O-methyldopa as measured by dried blood spot. Therefore, he was diagnosed with AADC deficiency. After treatment with the dopamine receptor agonist pramipexole dihydrochloride, the catechol-O-methyltransferase inhibitor entacapone, and vitamin B6, the boy showed mild improvements in hypotonia, blepharoptosis, and oculogyric crisis. Clinical physicians should enhance their ability for identifying AADC deficiency, so as to facilitate early diagnosis and treatment of this disorder. Genetic counseling for birth health and prenatal diagnosis should be performed for parents in need.
芳香族L-氨基酸脱羧酶(AADC)缺乏症是一种罕见的常染色体隐性遗传性疾病,是一种神经递质生物合成的先天性代谢紊乱。主要表现为肌张力减退、动眼危象、自主神经功能障碍和发育迟缓。本文报道一名表现为运动发育迟缓、肌张力减退和动眼危象的男孩。代谢紊乱的基因筛查显示,DDC基因外显子存在新的复合杂合突变,即c.1063dupA(p.I355fs)和c.250A>C(p.S84R)。通过干血斑检测,该男孩的3-O-甲基多巴显著增加。因此,他被诊断为AADC缺乏症。在使用多巴胺受体激动剂盐酸普拉克索、儿茶酚-O-甲基转移酶抑制剂恩他卡朋和维生素B6治疗后,该男孩的肌张力减退、上睑下垂和动眼危象有轻度改善。临床医生应提高识别AADC缺乏症的能力,以便于对该疾病进行早期诊断和治疗。应为有需要的父母提供出生健康遗传咨询和产前诊断。